Related Experiment Video
Updated: Dec 21, 2025
Screening of Axonal Degeneration in Carpal Tunnel Syndrome Using Ultrasonography and Nerve Conduction Studies
Published on: January 11, 2019
Screening for genetic mutations in patients with neuropathy without definite etiology is useful
Braden Vogt1, Nizar Chahin1, Wojciech Wiszniewski2
1Department of Neurology, Oregon Health and Science University, 3181 SW Sam Jackson Park Road, Portland, OR, L22697239-3098, USA.
Objective:
To determine the clinical usefulness of systemic genetic testing in neuropathies without definite etiology.
Methods:
We systematically performed genetic testing in all patients with neuropathy who did not have a definite etiology, seen at our neuromuscular clinic between 2017 and 2020. The testing consisted of an inherited neuropathy panel (72-81 genes), which used next-generation sequencing technology.
Results:
We screened 200 patients. Pathogenic mutations were found in 30 (15%). PMP22, TTR and GJB1, accounted for 83.3% of positive mutations. The management was altered in four patients (2%). Two patients were found to have hereditary transthyretin amyloidosis and were started on TTR gene silencers. Two patients were being treated for demyelinating autoimmune neuropathy and were diagnosed with CMT1A and CMTX.
Conclusion:
Screening for genetic mutations in patients with neuropathy without a definite etiology is useful. While only a minority of patients with unsuspected inherited neuropathy tested positive, the findings altered management in some, improving morbidity and, perhaps, mortality.
